cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Resmed Inc
14 own
5 watching
Current Price
$185.09
$-0.77
(-0.41%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
25,370.54M
52-Week High
52-Week High
243.52000
52-Week Low
52-Week Low
132.24001
Average Volume
Average Volume
0.61M
Dividend Yield
Dividend Yield
0.006102
P/E Ratio
P/E Ratio
76.5676
iconMarket Capitalization25,370.54M
icon52-Week High243.52000
icon52-Week Low132.24001
iconAverage Volume0.61M
iconDividend Yield0.006102
iconP/E Ratio76.5676
What does the Resmed Inc do?
ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More
How much money does Resmed Inc make?
News & Events about Resmed Inc.
Zolmax
10 months ago
ResMed Inc. (NYSE:RMD Get Rating) insider David Pendarvis sold 1,500 shares of ResMed stock in a transaction on Monday, June 5th. The stock was sold at an average price of $219.79, for a total transaction of $329,685.00. Following the transaction, the insider now directly owns 89,729 shares of the ...
Ticker Report
12 months ago
ResMed Inc. (NYSE:RMD Get Rating) COO Robert Andrew Douglas sold 1,500 shares of ResMed stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $224.65, for a total transaction of $336,975.00. Following the completion of the sale, the chief ...
Ticker Report
1 year ago
ResMed Inc. (NYSE:RMD Get Rating) CEO Michael J. Farrell sold 5,675 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $206.95, for a total transaction of $1,174,441.25. Following the sale, the chief executive officer now owns 436,900 ...
Zolmax
1 year ago
ResMed Inc. (NYSE:RMD Get Rating) CEO Michael J. Farrell sold 5,675 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $206.95, for a total transaction of $1,174,441.25. Following the sale, the chief executive officer now owns 436,900 shares ...
Frequently Asked Questions
Frequently Asked Questions
What is Resmed Inc share price today?
plus_minus_icon
Can Indians buy Resmed Inc shares?
plus_minus_icon
How can I buy Resmed Inc shares from India?
plus_minus_icon
Can Fractional shares of Resmed Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Resmed Inc stocks?
plus_minus_icon
What is today’s traded volume of Resmed Inc?
plus_minus_icon
What is today’s market capitalisation of Resmed Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Resmed Inc?
plus_minus_icon
What percentage is Resmed Inc down from its 52-Week High?
plus_minus_icon
What percentage is Resmed Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$185.09
$-0.77
(-0.41%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Baxter International Inc.
Baxter International Inc.
$40.04
$-0.29 (-0.72 %)
DENTSPLY International Inc.
DENTSPLY International Inc.
$30.89
$-0.41 (-1.31 %)
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
$378.81
$-1.19 (-0.31 %)
Teleflex Incorporated
Teleflex Incorporated
$210.66
$-3.78 (-1.76 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Baxter International Inc.
Baxter International Inc.
$40.04
$-0.29 (-0.72 %)
DENTSPLY International Inc.
DENTSPLY International Inc.
$30.89
$-0.41 (-1.31 %)
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
$378.81
$-1.19 (-0.31 %)
Teleflex Incorporated
Teleflex Incorporated
$210.66
$-3.78 (-1.76 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00